SS Innovations International (SSII) Depreciation & Amortization (CF) (2017 - 2026)
SS Innovations International's (SSII) quarterly Depreciation & Amortization (CF) came in at $346364.0 in Q2 2026, up 33.03% year-over-year from $260361.0 in Q2 2025, and up 6.99% quarter-over-quarter from $323747.0 in Q1 2026.
Analysis
SS Innovations International (SSII) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
SS Innovations International has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $346364.0 for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 33.03% year-over-year to $346364.0; the TTM figure through Jun 2026 stood at $1.3 million (up 73.79% YoY), while the FY2025 annual figure was $1.1 million, up 146.76% from the prior year.
- Depreciation & Amortization (CF) came in at $346364.0 for Q2 2026 at SS Innovations International, up from $323747.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $346364.0 in Q2 2026 to a low of $2305.0 in Q1 2022.
- Average Depreciation & Amortization (CF) over 5 years is $133884.0, with a median of $85288.5 recorded in 2024.
- Year-over-year, Depreciation & Amortization (CF) tumbled 68.59% in 2022 and surged 1313.93% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $24832.0 in 2022, then surged by 89.42% to $47037.0 in 2023, then surged by 210.24% to $145926.0 in 2024, then surged by 112.09% to $309491.0 in 2025, then grew by 11.91% to $346364.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $346364.0 in Q2 2026, $323747.0 in Q1 2026, and $309491.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 123.80 Mn |
| 10 | SS Innovations International | 650.44 Mn | 628.15 Mn | 7.10 Mn | 346,364.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 346,364.00 |
| Mar 31, 2026 | 323,747.00 |
| Dec 31, 2025 | 309,491.00 |
| Sep 30, 2025 | 297,173.00 |
| Jun 30, 2025 | 260,361.00 |
| Mar 31, 2025 | 208,882.00 |
| Dec 31, 2024 | 145,926.00 |
| Sep 30, 2024 | 119,502.00 |
| Jun 30, 2024 | 90,476.00 |
| Mar 31, 2024 | 80,101.00 |
| Dec 31, 2023 | 47,037.00 |
| Sep 30, 2023 | 38,644.00 |
| Jun 30, 2023 | 34,466.00 |
| Mar 31, 2023 | 32,591.00 |
| Dec 31, 2022 | 24,832.00 |
| Sep 30, 2022 | 24,712.00 |
| Jun 30, 2022 | 23,302.00 |
| Mar 31, 2022 | 2,305.00 |
| Dec 31, 2021 | 2,982.00 |
| Sep 30, 2021 | 3,267.00 |